No matter whether patients had CAD or not, the simpler regimen was linked to less mortality and major bleeding at 6 months.

GI bleeding after percutaneous coronary intervention among patients on dual antiplatelet therapy remains risky in terms of ...

Dual antiplatelet therapy with clopidogrel and aspirin can benefit patients with mild ischemic stroke when initiated up to 72 hours after symptom onset.

Antiplatelet use can lead to improved cardiovascular ... risks while benefiting from the protective effects of antiplatelet ...

Patients had had their strokes treated with IV thrombolysis in 22.0% of cases, and endovascular therapy in 7.3%. After the ...

Various clinical, demographic and genetic variables can influence responsiveness to antiplatelet therapy. In 2008, Geisler et al. 10 showed that residual platelet activity in patients with ...

Strategies for treating IC are aimed at improving symptoms and reducing the progression of atherosclerosis and include risk-factor modification, exercise, and antiplatelet therapy. Cilostazol and ...

Genomadix (genomadix.com), a global leader in point of need precision medicine diagnostics, announced today that it has entered into a know-how license agreement with Mayo Clinic to collaborate on the ...

For a minor nondisabling acute ischemic stroke, dual antiplatelet therapy was tied to better prevention of early neurological deterioration with a better safety profile compared with IV alteplase.

This particular finding is a major advance in the field of antiplatelet therapy and in the treatment of ACS in general. The benefits of ticagrelor over clopidogrel were extremely consistent across ...